When legal costs dent reported profit, the market tends to lose sight of the cash pulling up to the curb.
Stick with us, and you’ll see why this ride is worth hailing, and why the fare still looks cheap for you.
Your Next Revenue Stream is Hiding In Plain Sight
Your business has years of emails, documents, CRM records and call logs. AI researchers need exactly that kind of real-world data, and Mode will pay for it.
You sell a de-identified copy. Your original records and systems remain yours.
No broker fees. Mode buys directly.
You approve what data gets shared.
You never share your passwords.
Sensitive information is removed before delivery.
It takes just a few hours of your team’s time.
Depending on data volume and a full review, companies with several years of records could see 100K–5M.
See if your company qualifies and get a quote.
Shipping
Global Ship Lease Secures Revenue at Just 4 Times Earnings

Global Ship Lease (NYSE: GSL) reported $3.4 billion in contracted revenue, with 98% of its 2027 capacity already covered. Quarterly revenue reached $201.4 million, while earnings available to common shareholders climbed to $99.2 million from $92.6 million. The report also raised annualized dividends to $2.75 per share, reinforcing cash returns.
At $40.75, the company trades near 4 times trailing earnings, compared with roughly 5 times for fellow shipowner Danaos. A $1.47 billion market value reflects a modest price for a business with substantial contracted income.
Shipping carries a reputation for unpredictable earnings, but fixed contracts give you a clearer view of near-term revenue. Renewals at attractive rates could support profits even when daily freight prices fluctuate, as long as customers honor their commitments.
Fresh Ships, Longer Contracts
Fleet renewal adds another layer to the case. Fifteen new ships already have multiyear charters, while a $1 billion financing facility supports their purchase commitments. Deliveries beginning in late 2028 extend the business beyond its aging operating fleet.
The Discount Has Reasons
Your margin of safety depends on accounting for the bills ahead. Those 15 ships cost approximately $1.3 billion, and another 2 lack finalized charters and financing. Weaker renewal rates or delivery problems could keep the valuation discount in place.
Finance
AMG Draws Record Alternative Inflows at 9 Times Earnings

Affiliated Managers Group (NYSE: AMG) attracted $20.7 billion in quarterly net client inflows, including more than $31 billion into alternative strategies. Assets under management reached a record $974 billion, while adjusted EBITDA climbed 41% to approximately $354 million.
At $365.18, AMG trades near 9 times expected earnings, below T. Rowe Price at roughly 11 times. Its $9.44 billion market value suggests a restrained valuation, although differences in debt and business mix explain part of the gap.
Net inflows help you distinguish business growth from gains driven by rising markets. New client commitments can expand the assets generating fees, giving AMG another source of earnings growth when market performance alone offers less support. Continued inflows could strengthen the case for a higher valuation over time.
Alternatives Carry More Weight
Alternatives attracted enough money to offset $11.9 billion in equity outflows. AMG also repurchased $400 million of shares during the quarter, which helped lift economic earnings per share 56%, alongside growth in the underlying adjusted profit.
Growth Still Has Leaks
Continued equity withdrawals could push your earnings expectations lower despite strong alternative demand. Reported net income fell to $173.3 million from $212.4 million, with the comparison affected by a prior transaction gain. Buybacks support EPS without increasing underlying fee revenue.
The holiday streaming season is almost here
Are you ready? As revealed in our holiday playbook, Roku Ads Manager lets you easily set up, measure and optimize your self-serve holiday ad campaign. You can even create a shoppable ad unit that lets streamers buy directly from their remote.
Healthcare
Kamada Raises Outlook at 8 Times Adjusted EBITDA

Kamada (NASDAQ: KMDA) raised its annual outlook after quarterly net income rose 51% to $8 million. Revenue increased 11% to $52 million, while revised adjusted EBITDA guidance of $52 million to $54 million implies 26% growth at the midpoint. The company also projects double-digit revenue and profitability growth in 2027, with detailed guidance due in January next year.
At $7.47, Kamada has an estimated market value of $432 million. Including acquisition obligations and leases, enterprise value is approximately $425 million, or 8 times guided adjusted EBITDA, a modest multiple if the company delivers its projected growth.
KEDRAB is one of only 2 FDA-approved anti-rabies immunoglobulin products in the U.S. Limited competition matters. However, sales growth still needs to translate into cash after manufacturing and supply costs.
Plasma Adds Another Revenue Stream
Nine-month operating cash flow reached $37.6 million. Kamada is also expanding Texas plasma collection under an existing three-year supply agreement worth approximately $50 million, adding another revenue source alongside its established treatment portfolio.
Cash Comes With Commitments
Cash totals $75.3 million, or roughly $7.2 million after subtracting outstanding contingent and lease liabilities. Strong operating cash flow must continue to support your dividend outlook and planned expansion. Adjusted EBITDA also excludes costs, so reported profit remains an essential check.
Actionable Picks This Week
Lyft (NASDAQ: LYFT)
Lyft is the pink ride app you open when you need to get across town, and the stock has been stuck in traffic since its latest report. Roll down the window and look closer. Gross bookings grew in the double digits, active riders posted their eighth straight quarter of double-digit growth, and adjusted profit jumped.
Lyft has also generated more than $1 billion of free cash flow over the past year and keeps steering that cash into buybacks. A pile of legal, tax, and regulatory reserves and settlements pushed it to a small reported loss, and that’s the part the headlines grabbed.
Robotaxis are the wild card, but Lyft already matches riders with Waymo vehicles in Nashville, so it’s riding along rather than getting run over. \You’re paying under 8 times expected earnings, and that’s a fare worth flagging down.
Wix.com (NASDAQ: WIX)
Wix helps small businesses and side hustlers build websites without writing code, and its AI app builder, Base44, turns a plain description into a working app. The market fears AI will make website builders obsolete, so the stock trades far below its highs. Wix’s answer is more AI, just cheaper to run.
Management has slashed the computing costs behind Base44, targeting healthy margins in the second half after starting the year paper-thin, and plans to pour those savings into marketing. It also bought back more than a quarter of its shares in a spring tender offer, so every share you own claims a bigger slice.
Competition from AI rivals is the clear risk, so watch how Base44 holds up. Still, you’re getting the whole company for little more than a single year of sales. Results land Tuesday morning.
Barrick Mining (NYSE: B)
Barrick digs gold and copper out of mines across the Americas, Africa, and Asia, and with gold prices higher than a year ago, you’d expect its stock to shine. Instead, it trades well below its 52-week high.
The latest quarter added some polish. Adjusted earnings per share jumped, revenue climbed, and management reaffirmed its full-year production and cost guidance. Barrick also sent more than $1 billion back to you in a single quarter, mostly through buybacks, while holding more cash than debt.
Its big Mali mine is ramping up ahead of schedule too. The catch: the cost of digging each ounce jumped, and free cash flow fell sharply from a year ago, so that’s the vein to watch. Even so, you’re paying a low double-digit multiple of its current earnings pace for a miner sitting on a net cash pile.
Attio is the #1 fastest-growing CRM on Brex and Ramp.
Built for the most ambitious companies in GTM, Attio is an end to end revenue platform that allows teams to run multiple plays across different revenue motions and lifecycles.
Teams at the frontier are already building on it: Granola, turbopuffer, Modal, and many many more.
Fast Movers to Watch
Five9 (NASDAQ: FIVN) runs cloud software for customer service centers, the tech behind the hold music and, increasingly, the AI agent that answers first.
The stock got put on hold after the company trimmed its profit outlook, but look under the hood. Revenue grew in the double digits, AI revenue soared, and management lifted its full-year revenue guidance.
It’s also buying AI startup Level AI to deepen its bench. You’re paying under 9 times this year’s adjusted earnings guidance for a business that keeps landing bigger and bigger customers. Watch closely whether all that AI growth turns into fatter margins next year.Franklin Templeton (NYSE: BEN) manages money for people and institutions, from classic mutual funds to private credit and property.
After years of watching client cash walk out the door, its fiscal year just wrapped with long-term net inflows, adjusted earnings up by more than a third and wider operating margins.
Fundraising for its alternative investments stayed strong, and the dividend sits higher than a year ago. Its Western Asset bond unit is still leaking client money, so keep an eye right there. Even so, you’re paying a low double-digit multiple of last year’s adjusted earnings, with a dividend yielding north of 3.5%.eToro (NASDAQ: ETOR) runs a trading app where you can buy stocks and crypto or copy other users' trades, making it social media with a brokerage account.
The stock sits a stone’s throw from its 52-week low as crypto trading cooled off. Underneath, funded accounts keep growing at a double-digit pace, stock trading on the platform is picking up, and a deal to buy US broker TradeZero is pending.
You’re paying under 8 times expected earnings for a platform that keeps signing up customers. Third-quarter results land Tuesday morning, so watch whether profits keep pace with all the sign-ups.
A boring cash-printer, or an expensive stock that might change the world?
Everything Else
Argenx agreed to acquire Unnatural Products, a developer of macrocyclic peptide drugs, for up to $1.15 billion.
TG Therapeutics raised its full-year global revenue guidance to $1 billion as sales of its multiple sclerosis drug Briumvi climbed.
QXO reported preliminary third-quarter sales that jumped from a year ago, helped by its Kodiak and TopBuild acquisitions.
Nvidia’s board opened an independent investigation into reports that CEO Jensen Huang was targeted by a foreign intelligence effort.
That's our coverage for today; thanks for reading! Reply to this email with feedback or any stocks you want me to check out.
Best Regards,
—Noah Zelvis
Undervalued Edge





